Clinical Trial Update: Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating naltrexone plus ketamine for rapid treatment of major depressive disorder and alcohol use disorder completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Major Depressive Disorder

Drugs mentioned

• Naltrexone + Ketamine

Snippet

Sponsor: VA Connecticut Healthcare System | Conditions: Major Depressive Disorder, Alcohol Use Disorder | Phase 2 | Status: COMPLETED